Lassa virus cell entry via dystroglycan involves an unusual pathway of macropinocytosis

Journal of Virology

Volumn 90, Issue 14, 2016, Pages 6412-6429

  Oppliger, Joel ^a   Torriani, Giulia ^a   Herrador, Antonio ^a   Kunz, Stefan ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DYSTROGLYCAN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; P21 ACTIVATED KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CDC42; PROTEIN KINASE C; RIBAVIRIN; SCATTER FACTOR RECEPTOR; TEPOTINIB; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR; WAS PROTEIN, HUMAN; WISKOTT ALDRICH SYNDROME PROTEIN;

ANTIVIRAL ACTIVITY; ARENAVIRUS INFECTION; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FLUID TRANSPORT; HUMAN; HUMAN CELL; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ATTACHMENT; VIRUS ENTRY; A-549 CELL LINE; ENDOSOME; EPITHELIUM CELL; LASSA FEVER; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

A549 CELLS; DYSTROGLYCANS; ENDOSOMES; EPITHELIAL CELLS; HUMANS; LASSA FEVER; LASSA VIRUS; PHOSPHATIDYLINOSITOL 3-KINASES; PINOCYTOSIS; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION; VIRUS INTERNALIZATION; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84977597990     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00257-16     Document Type: Article

References (85)

1. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever. Curr Top Microbiol Immunol 262:75-109.
2. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: progress and challenges. Nat Med 10:S110-S121. http://dx.doi.org/10.1038/nm1142.
3. Andersen KG, Shapiro BJ, Matranga CB, Sealfon R, Lin AE, Moses LM, Folarin OA, Goba A, Odia I, Ehiane PE, Momoh M, England EM, Winnicki S, Branco LM, Gire SK, Phelan E, Tariyal R, Tewhey R, Omoniwa O, Fullah M, Fonnie R, Fonnie M, Kanneh L, Jalloh S, Gbakie M, Saffa S, Karbo K, Gladden AD, Qu J, Stremlau M, Nekoui M, Finucane HK, Tabrizi S, Vitti JJ, Birren B, Fitzgerald M, McCowan C, Ireland A, Berlin AM, Bochicchio J, Tazon-Vega B, Lennon NJ, Ryan EM, Bjornson Z, Milner DA, Jr, Lukens AK, Broodie N, Rowland M, Heinrich M, Akdag M, et al. 2015. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162:738-750. http://dx.doi.org/10.1016/j.cell.2015.07.020.
4. Stephenson EH, Larson EW, Dominik JW. 1984. Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol 14:295-303. http://dx.doi.org/10.1002/jmv.1890140402.
5. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM, Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287: 2391-2405. http://dx.doi.org/10.1001/jama.287.18.2391.
6. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. 1986. Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20-26.
7. Buchmeier MJ, de la Torre JC, Peters CJ. 2007. Arenaviridae: the viruses and their replication, p 1791-1828. In Knipe DL, Howley PM, Chanock RM, Melnick JL, Monathy TP, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
8. de la Torre JC. 2009. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. Ann N Y Acad Sci 1171(Suppl 1):E57-E64. http://dx.doi.org/10.1111/j.1749-6632.2009.05048.x.
9. Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W. 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A 98:12701-12705. http://dx.doi.org/10.1073/pnas.221447598.
10. Igonet S, Vaney MC, Vonhrein C, Bricogne G, Stura EA, Hengartner H, Eschli B, Rey FA. 2011. X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A 108:19967-19972. http://dx.doi.org/10.1073/pnas.1108910108.
11. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, Smith ES, Trippel S, Tong TC. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445-455. http://dx.doi.org/10.1093/infdis/155.3.445.
12. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu Rev Biochem 79:803-833. http://dx.doi.org/10.1146/annurev-biochem-060208-104626.
13. Yamauchi Y, Helenius A. 2013. Virus entry at a glance. J Cell Sci 126: 1289-1295. http://dx.doi.org/10.1242/jcs.119685.
14. Marsh M, Helenius A. 2006. Virus entry: open sesame. Cell 124:729-740. http://dx.doi.org/10.1016/j.cell.2006.02.007.
15. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081. http://dx.doi.org/10.1126/science.282.5396.2079.
16. Barresi R, Campbell KP. 2006. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119:199-207. http://dx.doi.org/10.1242/jcs.02814.
17. Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, Muschler J, Dumanski JP, Michele DE, Oldstone MB, Campbell KP. 2004. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117:953-964. http://dx.doi.org/10.1016/j.cell.2004.06.003.
18. Kunz S, Rojek JM, Kanagawa M, Spiropoulou CF, Barresi R, Campbell KP, Oldstone MB. 2005. Posttranslational modification of alphadystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol 79:14282-14296. http://dx.doi.org/10.1128/JVI.79.22.14282-14296.2005.
19. Rojek JM, Spiropoulou CF, Campbell KP, Kunz S. 2007. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J Virol 81:5685-5695. http://dx.doi.org/10.1128/JVI.02574-06.
20. Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP. 2013. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature 503:136-140. http://dx.doi.org/10.1038/nature12605.
21. Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP. 2012. Dystroglycan function requires xylosyl-and glucuronyltransferase activities of LARGE. Science 335:93-96. http://dx.doi.org/10.1126/science.1214115.
22. Yoshida-Moriguchi T, Campbell KP. 2015. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology 25:702-713. http://dx.doi.org/10.1093/glycob/cwv021.
23. Jae LT, Raaben M, Riemersma M, van Beusekom E, Blomen VA, Velds A, Kerkhoven RM, Carette JE, Topaloglu H, Meinecke P, Wessels MW, Lefeber DJ, Whelan SP, van Bokhoven H, Brummelkamp TR. 2013. Deciphering the glycosylome of dystroglycanopathies using haploid screens for Lassa virus entry. Science 340:479-483. http://dx.doi.org/10.1126/science.1233675.
24. Shimojima M, Stroher U, Ebihara H, Feldmann H, Kawaoka Y. 2012. Identification of cell surface molecules involved in dystroglycanindependent Lassa virus cell entry. J Virol 86:2067-2078. http://dx.doi.org/10.1128/JVI.06451-11.
25. Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S. 2013. Role of DC-SIGN in Lassa virus entry into human dendritic cells. J Virol 87:11504-11515. http://dx.doi.org/10.1128/JVI.01893-13.
26. Lemke G, Burstyn-Cohen T. 2010. TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci 1209:23-29. http://dx.doi.org/10.1111/j.1749-6632.2010.05744.x.
27. Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pecheur EI, ter Meulen J, Deubel V, Bartosch B. 2009. Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol 83: 3228-3237. http://dx.doi.org/10.1128/JVI.01711-08.
28. Klewitz C, Klenk HD, ter Meulen J. 2007. Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity. J Gen Virol 88:2320-2328. http://dx.doi.org/10.1099/vir.0.82950-0.
29. Vela EM, Zhang L, Colpitts TM, Davey RA, Aronson JF. 2007. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 369:1-11. http://dx.doi.org/10.1016/j.virol.2007.07.014.
30. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S. 2008. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82:7677-7687. http://dx.doi.org/10.1128/JVI.00560-08.
31. Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S. 2011. Old World arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7:e1002232. http://dx.doi.org/10.1371/journal.ppat.1002232.
32. Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, Barrows NJ, Pearson JL, Thompson J, Kelly DL, Ladunga I, Pattnaik AK. 2011. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A 108:19036-19041. http://dx.doi.org/10.1073/pnas.1113643108.
33. Mercer J, Helenius A. 2009. Virus entry by macropinocytosis. Nat Cell Biol 11:510-520. http://dx.doi.org/10.1038/ncb0509-510.
34. Iwasaki M, Ngo N, de la Torre JC. 2014. Sodium hydrogen exchangers contribute to arenavirus cell entry. J Virol 88:643-654. http://dx.doi.org/10.1128/JVI.02110-13.
35. Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, Soh TK, Stubbs SH, Janssen H, Damme M, Saftig P, Whelan SP, Dye JM, Brummelkamp TR. 2014. Virus entry. Lassa virus entry requires a triggerinduced receptor switch. Science 344:1506-1510. http://dx.doi.org/10.1126/science.1252480.
36. Jae LT, Brummelkamp TR. 2015. Emerging intracellular receptors for hemorrhagic fever viruses. Trends Microbiol 23:392-400. http://dx.doi.org/10.1016/j.tim.2015.04.006.
37. Buchmeier MJ, Lewicki HA, Tomori O, Oldstone MB. 1981. Monoclonal antibodies to lymphocytic choriomeningitis and Pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology 113:73-85. http://dx.doi.org/10.1016/0042-6822(81)90137-9.
38. Pinschewer DD, Perez M, Sanchez AB, de la Torre JC. 2003. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A 100:7895-7900. http://dx.doi.org/10.1073/pnas.1332709100.
39. Rojek JM, Spiropoulou CF, Kunz S. 2006. Characterization of the cellular receptors for the South American hemorrhagic fever viruses Junin, Guanarito, and Machupo. Virology 349:476-491. http://dx.doi.org/10.1016/j.virol.2006.02.033.
40. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol 155:301-310. http://dx.doi.org/10.1083/jcb.200104103.
41. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. http://dx.doi.org/10.1126/science.1155164.
42. Lutschg V, Boucke K, Hemmi S, Greber UF. 2011. Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nat Commun 2:391. http://dx.doi.org/10.1038/ncomms1391.
43. Krieger SE, Kim C, Zhang L, Marjomaki V, Bergelson JM. 2013. Echovirus 1 entry into polarized Caco-2 cells depends on dynamin, cholesterol, and cellular factors associated with macropinocytosis. J Virol 87: 8884-8895. http://dx.doi.org/10.1128/JVI.03415-12.
44. Kunz S, Sevilla N, Rojek JM, Oldstone MB. 2004. Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology 325:432-445. http://dx.doi.org/10.1016/j.virol.2004.05.009.
45. Pohl MO, Edinger TO, Stertz S. 2014. Prolidase is required for early trafficking events during influenza A virus entry. J Virol 88:11271-11283. http://dx.doi.org/10.1128/JVI.00800-14.
46. Buehler E, Chen YC, Martin S. 2012. C911: a bench-level control for sequence specific siRNA off-target effects. PLoS One 7:e51942. http://dx.doi.org/10.1371/journal.pone.0051942.
47. Rojek JM, Campbell KP, Oldstone MB, Kunz S. 2007. Old World arenavirus infection interferes with the expression of functional alphadystroglycan in the host cell. Mol Biol Cell 18:4493-4507. http://dx.doi.org/10.1091/mbc.E07-04-0374.
48. Kunz S, Edelmann KH, de la Torre J-C, Gorney R, Oldstone MBA. 2003. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology 314:168-178. http://dx.doi.org/10.1016/S0042-6822(03)00421-5.
49. de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jimenez V, Scholte F, Garcia-Sastre A, Rottier PJ, de Haan CA. 2011. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7:e1001329. http://dx.doi.org/10.1371/journal.ppat.1001329.
50. Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A. 2013. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog 9:e1003309. http://dx.doi.org/10.1371/journal.ppat.1003309.
51. Durbeej M, Campbell KP. 1999. Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem 274:26609-26616. http://dx.doi.org/10.1074/jbc.274.37.26609.
52. Lemke G, Rothlin CV. 2008. Immunobiology of the TAM receptors. Nat Rev Immunol 8:327-336. http://dx.doi.org/10.1038/nri2303.
53. Moraz ML, Pythoud C, Turk R, Rothenberger S, Pasquato A, Campbell KP, Kunz S. 2013. Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan. Cell Microbiol 15:689-700. http://dx.doi.org/10.1111/cmi.12078.
54. Rojek JM, Moraz ML, Pythoud C, Rothenberger S, Van der Goot FG, Campbell KP, Kunz S. 2012. Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan. Cell Microbiol 14: 1122-1134. http://dx.doi.org/10.1111/j.1462-5822.2012.01784.x.
55. Lee AM, Cruite J, Welch MJ, Sullivan B, Oldstone MB. 2013. Pathogenesis of Lassa fever virus infection. I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus. Virology 442:114-121. http://dx.doi.org/10.1016/j.virol.2013.04.010.
56. Sommerstein R, Ramos da Palma J, Olschlager S, Bergthaler A, Barba L, Lee BP, Pasquato A, Flatz L. 2014. Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness. J Virol 88:8340-8348. http://dx.doi.org/10.1128/JVI.00236-14.
57. Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, Monahan S, Bu X, Farzan M, Freeman GJ, Umetsu DT, Dekruyff RH, Choe H. 2013. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog 9:e1003232. http://dx.doi.org/10.1371/journal.ppat.1003232.
58. Ohkuma S, Poole B. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 75:3327-3331. http://dx.doi.org/10.1073/pnas.75.7.3327.
59. Ohkuma S, Poole B. 1981. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 90:656-664. http://dx.doi.org/10.1083/jcb.90.3.656.
60. Lozach PY, Huotari J, Helenius A. 2011. Late-penetrating viruses. Curr Opin Virol 1:35-43. http://dx.doi.org/10.1016/j.coviro.2011.05.004.
61. Leonoudakis D, Huang G, Akhavan A, Fata JE, Singh M, Gray JW, Muschler JL. 2014. Endocytic trafficking of laminin is controlled by dystroglycan and is disrupted in cancers. J Cell Sci 127:4894-4903. http://dx.doi.org/10.1242/jcs.152728.
62. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A. 2009. Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83:440-453. http://dx.doi.org/10.1128/JVI.01864-08.
63. von Kleist L, Stahlschmidt W, Bulut H, Gromova K, Puchkov D, Robertson MJ, MacGregor KA, Tomilin N, Pechstein A, Chau N, Chircop M, Sakoff J, von Kries JP, Saenger W, Krausslich HG, Shupliakov O, Robinson PJ, McCluskey A, Haucke V. 2011. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146:471-484. http://dx.doi.org/10.1016/j.cell.2011.06.025.
64. Mercer J, Helenius A. 2012. Gulping rather than sipping: macropinocytosis as a way of virus entry. Curr Opin Microbiol 15:490-499. http://dx.doi.org/10.1016/j.mib.2012.05.016.
65. Banerjee I, Miyake Y, Nobs SP, Schneider C, Horvath P, Kopf M, Matthias P, Helenius A, Yamauchi Y. 2014. Influenza A virus uses the aggresome processing machinery for host cell entry. Science 346:473-477. http://dx.doi.org/10.1126/science.1257037.
66. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S. 2010. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188:547-563. http://dx.doi.org/10.1083/jcb.200908086.
67. McEwan GT, Jepson MA, Hirst BH, Simmons NL. 1993. Polycationinduced enhancement of epithelial paracellular permeability is independent of tight junctional characteristics. Biochim Biophys Acta 1148:51-60. http://dx.doi.org/10.1016/0005-2736(93)90159-W.
68. Bose S, Basu M, Banerjee AK. 2004. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 78: 8146-8158. http://dx.doi.org/10.1128/JVI.78.15.8146-8158.2004.
69. Dylla DE, Michele DE, Campbell KP, McCray PB, Jr. 2008. Basolateral entry and release of New and Old World arenaviruses from human airway epithelia. J Virol 82:6034-6038. http://dx.doi.org/10.1128/JVI.00100-08.
70. Driss A, Charrier L, Yan Y, Nduati V, Sitaraman S, Merlin D. 2006. Dystroglycan receptor is involved in integrin activation in intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 290:G1228-G1242. http://dx.doi.org/10.1152/ajpgi.00378.2005.
71. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. 2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96. http://dx.doi.org/10.1038/nature05539.
72. Gentile A, Trusolino L, Comoglio PM. 2008. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 27:85-94. http://dx.doi.org/10.1007/s10555-007-9107-6.
73. Skead G, Govender D. 2015. Gene of the month: MET. J Clin Pathol 68:405-409. http://dx.doi.org/10.1136/jclinpath-2015-203050.
74. Bladt F, Faden B, Friese-Hamim M, Knuehl C, Wilm C, Fittschen C, Gradler U, Meyring M, Dorsch D, Jaehrling F, Pehl U, Stieber F, Schadt O, Blaukat A. 2013. EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors. Clin Cancer Res 19: 2941-2951. http://dx.doi.org/10.1158/1078-0432.CCR-12-3247.
75. Parker WB. 2005. Metabolism and antiviral activity of ribavirin. Virus Res 107:165-171. http://dx.doi.org/10.1016/j.virusres.2004.11.006.
76. Kunz S, Rojek JM, Perez M, Spiropoulou CF, Oldstone MB. 2005. Characterization of the interaction of Lassa fever virus with its cellular receptor alpha-dystroglycan. J Virol 79:5979-5987. http://dx.doi.org/10.1128/JVI.79.10.5979-5987.2005.
77. Van Breedam W, Pohlmann S, Favoreel HW, de Groot RJ, Nauwynck HJ. 2014. Bitter-sweet symphony: glycan-lectin interactions in virus biology. FEMS Microbiol Rev 38:598-632. http://dx.doi.org/10.1111/1574-6976.12052.
78. Amara A, Mercer J. 2015. Viral apoptotic mimicry. Nat Rev Microbiol 13:461-469. http://dx.doi.org/10.1038/nrmicro3469.
79. Mohr EL, McMullan LK, Lo MK, Spengler JR, Bergeron E, Albarino CG, Shrivastava-Ranjan P, Chiang CF, Nichol ST, Spiropoulou CF, Flint M. 2015. Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antiviral Res 120:40-47. http://dx.doi.org/10.1016/j.antiviral.2015.05.003.
80. Pietiainen V, Marjomaki V, Upla P, Pelkmans L, Helenius A, Hyypia T. 2004. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 15:4911-4925. http://dx.doi.org/10.1091/mbc.E04-01-0070.
81. Sanchez EG, Quintas A, Perez-Nunez D, Nogal M, Barroso S, Carrascosa AL, Revilla Y. 2012. African swine fever virus uses macropinocytosis to enter host cells. PLoS Pathog 8:e1002754. http://dx.doi.org/10.1371/journal.ppat.1002754.
82. Rossman JS, Leser GP, Lamb RA. 2012. Filamentous influenza virus enters cells via macropinocytosis. J Virol 86:10950-10960. http://dx.doi.org/10.1128/JVI.05992-11.
83. Veettil VM, Kumar B, Ansari MA, Dutta D, Iqbal J, Gjyshi O, Bottero V, Chandran B. 2016. ESCRT-0 component Hrs promotes macropinocytosis of Kaposi's sarcoma-associated herpesvirus in human dermal microvascular endothelial cells. J Virol 90:3860-3872. http://dx.doi.org/10.1128/JVI.02704-15.
84. Dowrick P, Kenworthy P, McCann B, Warn R. 1993. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells. Eur J Cell Biol 61:44-53.
85. Lee AM, Pasquato A, Kunz S. 2011. Novel approaches in anti-arenaviral drug development. Virology 411:163-169. http://dx.doi.org/10.1016/j.virol.2010.11.022.